{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Hedysarum polybotrys polysaccharide", "diabetic kidney disease", "fibrosis", "high mobility group box 1/receptor for advanced glycation endproducts/toll-like receptor 4 pathway", "inflammatory"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37771649", "DateRevised": {"Year": "2023", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "06"}], "Language": ["eng"], "ELocationID": ["493", "10.3892/etm.2023.12192"], "Journal": {"ISSN": "1792-1015", "JournalIssue": {"Volume": "26", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Oct"}}, "Title": "Experimental and therapeutic medicine", "ISOAbbreviation": "Exp Ther Med"}, "ArticleTitle": "<i>Hedysarum polybotrys</i> polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway.", "Pagination": {"StartPage": "493", "MedlinePgn": "493"}, "Abstract": {"AbstractText": ["Diabetic kidney disease (DKD) is a leading cause of kidney failure. Previous studies demonstrated the therapeutic potential of Astragalus polysaccharide in treating diabetic nephropathy. Astragalus and Hongqi both come from the leguminous plant Astragalus, but their species and genera are different, belonging to the same family and different genera of traditional Chinese medicinal plants. However, the effects of <i>Hedysarum polybotrys</i> polysaccharide (HPS), a polysaccharide compound from Hongqi, on DKD, including its components and efficacy, have remained elusive. The present study utilized db/db mice as a DKD animal model administered with low (30 mg/kg) and high doses (60 mg/kg) of HPS, in addition to glyburide (7.2 mg/kg). Blood and urine samples were collected from mice and blood glucose, serum creatinine, urinary albumin excretion and urinary \u03b22-microglobulin were measured. In addition, apoptosis and histological changes in kidney tissue were observed using TUNEL and HE staining, respectively, and the secretion and expression of inflammatory factors in kidney tissue were detected using EILSA and reverse transcription-quantitative PCR. Furthermore, we the expression of fibrosis-related proteins and NF-\u03baB signaling pathway proteins was determined using western blot analysis. HPS was found to reduce the blood glucose concentration, serum creatinine levels, urinary albumin excretion rates and urinary \u03b22-microglobulin in a dose-dependent manner. In addition, HPS treatment mitigated apoptosis and pathological damage in the kidney tissues of DKD mice. The expression levels of fibrosis-related proteins fibronectin, \u03b1-smooth muscle actin and TGF-\u03b21 were observed to be decreased in kidney tissues of DKD mice following HPS treatment. The secretion levels of inflammatory factors (IL-6, TNF-\u03b1 and IL-1\u03b2) were also reduced in kidney tissues, with high-dose HPS treatment found to be more effective, similar to the effects mediated by the glyburide. Further mechanistic analysis revealed that the therapeutic effects of HPS on DKD mice may be mediated by inhibiting the high mobility group box 1/receptor for advanced glycation end-products/toll-like receptor 4 pathway. In conclusion, the present findings could provide insight for the treatment of DKD."], "CopyrightInformation": "Copyright: \u00a9 2023, Spandidos Publications."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical College of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730000, P.R. China."}], "LastName": "Xu", "ForeName": "Changqing", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical College of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730000, P.R. China."}], "LastName": "Chen", "ForeName": "Yanxu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi 710077, P.R. China."}], "LastName": "Liu", "ForeName": "Zongmei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hyperbaric Oxygen Chamber, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an, Shaanxi 710077, P.R. China."}], "LastName": "Fu", "ForeName": "Xiaoyan", "Initials": "X"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Exp Ther Med", "NlmUniqueID": "101531947", "ISSNLinking": "1792-0981"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rousseau M, Denhez B, Spino C, Lizotte F, Guay A, C\u00f4t\u00e9 AM, Burger D, Geraldes P. Reduction of DUSP4 contributes to podocytes oxidative stress, insulin resistance and diabetic nephropathy. Biochem Biophys Res Commun. 2022;624:127\u2013133. doi: 10.1016/j.bbrc.2022.07.067.", "ArticleIdList": ["10.1016/j.bbrc.2022.07.067", "35940125"]}, {"Citation": "Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021;18(14791641211058856) doi: 10.1177/14791641211058856.", "ArticleIdList": ["10.1177/14791641211058856", "PMC8606936", "34791910"]}, {"Citation": "Giralt-L\u00f3pez A, Molina-Van den Bosch M, Vergara A, Garc\u00eda-Carro C, Seron D, Jacobs-Cach\u00e1 C, Soler MJ. Revisiting experimental models of diabetic nephropathy. Int J Mol Sci. 2020;21(3587) doi: 10.3390/ijms21103587.", "ArticleIdList": ["10.3390/ijms21103587", "PMC7278948", "32438732"]}, {"Citation": "Tang PM, Zhang YY, Hung JS, Chung JY, Huang XR, To KF, Lan HY. DPP4/CD32b/NF-\u03baB Circuit: A novel druggable target for inhibiting CRP-Driven diabetic nephropathy. Mol Ther. 2021;29:365\u2013375. doi: 10.1016/j.ymthe.2020.08.017.", "ArticleIdList": ["10.1016/j.ymthe.2020.08.017", "PMC7790911", "32956626"]}, {"Citation": "Zhang Z, Zhang L, Xu H. Effect of Astragalus polysaccharide in treatment of diabetes mellitus: A narrative review. J Tradit Chin Med. 2019;39:133\u2013138.", "ArticleIdList": ["32186034"]}, {"Citation": "Yang S, Wang L, Xie Z, Zeng Y, Xiong Q, Pei T, Wei D, Cheng W. The combination of salidroside and hedysari radix polysaccharide inhibits mitochondrial damage and apoptosis via the PKC/ERK Pathway. Evid Based Complement Alternat Med. 2022;2022(9475703) doi: 10.1155/2022/9475703.", "ArticleIdList": ["10.1155/2022/9475703", "PMC9252633", "35795284"]}, {"Citation": "Tang JL, Xin M, Zhang LC. Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury. Aging. 2022;14:5855\u20135877. doi: 10.18632/aging.204189. 35859295.", "ArticleIdList": ["10.18632/aging.204189", "PMC9365550", "35859295"]}, {"Citation": "Meng X, Wei M, Wang D, Qu X, Zhang K, Zhang N, Li X. Astragalus polysaccharides protect renal function and affect the TGF-\u03b2/Smad signaling pathway in streptozotocin-induced diabetic rats. J Int Med Res. 2020;48(300060520903612) doi: 10.1177/0300060520903612.", "ArticleIdList": ["10.1177/0300060520903612", "PMC7263164", "32475187"]}, {"Citation": "Tang JL, Xin M, Zhang LC. Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury. Aging (Albany NY) 2022;14:5855\u20135877. doi: 10.18632/aging.204189.", "ArticleIdList": ["10.18632/aging.204189", "PMC9365550", "35859295"]}, {"Citation": "Zhang Y, Tao C, Xuan C, Jiang J, Cao W. Transcriptomic analysis reveals the protection of astragaloside IV against diabetic nephropathy by modulating inflammation. Oxid Med Cell Longev. 2020;2020(9542165) doi: 10.1155/2020/9542165.", "ArticleIdList": ["10.1155/2020/9542165", "PMC7443226", "32855769"]}, {"Citation": "Zhang YY, Tan RZ, Zhang XQ, Yu Y, Yu C. Calycosin ameliorates diabetes-induced renal inflammation via the NF-\u03baB pathway in vitro and in vivo. Med Sci Monit. 2019;25:1671\u20131678. doi: 10.12659/MSM.915242.", "ArticleIdList": ["10.12659/MSM.915242", "PMC6413560", "30830898"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J. 2022;46:181\u2013197. doi: 10.4093/dmj.2021.0329.", "ArticleIdList": ["10.4093/dmj.2021.0329", "PMC8987689", "35385633"]}, {"Citation": "Hu F, Li X, Zhao L, Feng S, Wang C. Antidiabetic properties of purified polysaccharide from Hedysarum polybotrys. Can J Physiol Pharmacol. 2010;88:64\u201372. doi: 10.1139/Y09-098.", "ArticleIdList": ["10.1139/Y09-098", "20130740"]}, {"Citation": "Feng H, Zhu X, Tang Y, Fu S, Kong B, Liu X. Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation. Int J Mol Med. 2021;48(164) doi: 10.3892/ijmm.2021.4996.", "ArticleIdList": ["10.3892/ijmm.2021.4996", "PMC8262660", "34278447"]}, {"Citation": "Wang E, Wang L, Ding R, Zhai M, Ge R, Zhou P, Wang T, Fang H, Wang J, Huang J. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy. Pharmacol Res. 2020;157(104831) doi: 10.1016/j.phrs.2020.104831.", "ArticleIdList": ["10.1016/j.phrs.2020.104831", "32339782"]}, {"Citation": "Behl T, Sharma E, Sehgal A, Kaur I, Kumar A, Arora R, Pal G, Kakkar M, Kumar R, Bungau S. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs. Mol Biol Rep. 2021;48:1869\u20131881. doi: 10.1007/s11033-020-06130-x.", "ArticleIdList": ["10.1007/s11033-020-06130-x", "33479829"]}, {"Citation": "Huang J, Zeng T, Tian Y, Wu Y, Yu J, Pei Z, Tan L. Clinical significance of high-mobility group box-1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD) J Clin Lab Anal. 2010;33(e22910)", "ArticleIdList": ["PMC6642301", "31129918"]}, {"Citation": "Zhou Y, Liu SX, Zhou YN, Wang J, Ji R. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus. Eur Rev Med Pharmacol Sci. 2021;25:1339\u20131350. doi: 10.26355/eurrev_202102_24841.", "ArticleIdList": ["10.26355/eurrev_202102_24841", "33629304"]}, {"Citation": "Santangelo C, Filardi T, Perrone G, Mariani M, Mari E, Scazzocchio B, Masella R, Brunelli R, Lenzi A, Zicari A, Morano S. Cross-talk between fetal membranes and visceral adipose tissue involves HMGB1-RAGE and VIP-VPAC2 pathways in human gestational diabetes mellitus. Acta Diabetol. 2019;56:681\u2013689. doi: 10.1007/s00592-019-01304-x.", "ArticleIdList": ["10.1007/s00592-019-01304-x", "30820673"]}, {"Citation": "Yang L, Zhou L, Wang X, Wang W, Wang J. Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice. Int Immunopharmacol. 2020;89(Pt A)(106987) doi: 10.1016/j.intimp.2020.106987.", "ArticleIdList": ["10.1016/j.intimp.2020.106987", "33217691"]}, {"Citation": "Wang J, Wang L, Zhou J, Qin A, Chen Z. The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice. Biomed Pharmacother. 2018;106:1250\u20131257. doi: 10.1016/j.biopha.2018.07.063.", "ArticleIdList": ["10.1016/j.biopha.2018.07.063", "30119194"]}, {"Citation": "El-Azab MF, Al-Karmalawy AA, Antar SA, Hanna PA, Tawfik KM, Hazem RM. A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways. Life Sci. 2022;303(120691) doi: 10.1016/j.lfs.2022.120691.", "ArticleIdList": ["10.1016/j.lfs.2022.120691", "35671809"]}, {"Citation": "Chen X, Ma J, Kwan T, Stribos EGD, Messchendorp AL, Loh YW, Wang X, Paul M, Cunningham EC, Habib M, et al. Blockade of HMGB1 attenuates diabetic nephropathy in mice. Sci Rep. 2018;8(8319) doi: 10.1038/s41598-018-26637-5.", "ArticleIdList": ["10.1038/s41598-018-26637-5", "PMC5974129", "29844451"]}, {"Citation": "Zhou B, Li Q, Wang J, Chen P, Jiang S. Ellagic acid attenuates streptozocin induced diabetic nephropathy via the regulation of oxidative stress and inflammatory signaling. Food Chem Toxicol. 2019;123:16\u201327. doi: 10.1016/j.fct.2018.10.036.", "ArticleIdList": ["10.1016/j.fct.2018.10.036", "30342113"]}, {"Citation": "Zhang Y. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-\u03b21 pathway. Biosci Rep. 2021;41(BSR20203131) doi: 10.1042/BSR20203131.", "ArticleIdList": ["10.1042/BSR20203131", "PMC8485393", "33729484"]}, {"Citation": "P\u00e9rez-Morales RE, Del Pino MD, Valdivielso JM, Ortiz A, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF. Inflammation in Diabetic Kidney Disease. Nephron. 2019;143:12\u201316. doi: 10.1159/000493278.", "ArticleIdList": ["10.1159/000493278", "30273931"]}, {"Citation": "Wang S, Dong J, Huang L. Cytokine polymorphisms and predisposition to diabetic nephropathy: A meta-analysis. Int Arch Allergy Immunol. 2021;182:158\u2013165. doi: 10.1159/000510250.", "ArticleIdList": ["10.1159/000510250", "33285547"]}, {"Citation": "Ara\u00fajo LS, Torquato BGS, da Silva CA, Dos Reis Monteiro MLG, Dos Santos Martins ALM, da Silva MV, Dos Reis MA, Machado JR. Renal expression of cytokines and chemokines in diabetic nephropathy. BMC Nephrol. 2020;21(308) doi: 10.1186/s12882-020-01960-0.", "ArticleIdList": ["10.1186/s12882-020-01960-0", "PMC7389446", "32723296"]}, {"Citation": "Guan Y, Davis L, Breyer MD, Hao CM. Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor. Prostaglandins Other Lipid Mediat. 2022;159(106621) doi: 10.1016/j.prostaglandins.2022.106621.", "ArticleIdList": ["10.1016/j.prostaglandins.2022.106621", "35131551"]}, {"Citation": "Wang L, Wang HL, Liu TT, Lan HY. TGF-Beta as a master regulator of diabetic nephropathy. Int J Mol Sci. 2021;22(7881) doi: 10.3390/ijms22157881.", "ArticleIdList": ["10.3390/ijms22157881", "PMC8345981", "34360646"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "17"}, {"Year": "2023", "Month": "5", "Day": "31"}, {"Year": "2023", "Month": "9", "Day": "29", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "9", "Day": "29", "Hour": "6", "Minute": "44"}, {"Year": "2023", "Month": "9", "Day": "29", "Hour": "3", "Minute": "52"}, {"Year": "2023", "Month": "9", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["37771649", "PMC10523352", "10.3892/etm.2023.12192", "ETM-26-4-12192"]}}], "PubmedBookArticle": []}